Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $13.14 USD
Change Today -0.04 / -0.30%
Volume 8.1K
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Key Developments

Misonix Signs Exclusive Supply Agreement with MedAssets

Misonix announced the launch of an exclusive three-year national supply contract with MedAssets. With MedAssets serving four out of five US hospitals and approximately 123,000 non-acute healthcare providers, Misonix has entered into this exclusive agreement for its BoneScalpel and SonicOne surgical technologies. This is simply a great opportunity for many more healthcare facilities and their patients to ultimately benefit from its BoneScalpel and SonicOne surgical technologies.

Misonix Enters into an Exclusive Three-Year National Supply Contract with MedAssets

Misonix has entered into an exclusive three-year national supply contract with MedAssets. MedAssets manages approximately $59 billion in annual supply spend on behalf of its clients. Misonix designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.

Misonix, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014

Misonix, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the quarter, the company reported net sales of $5,601,008 against $4,122,059 a year ago. Loss from operations was $110,426 against $346,994 a year ago. Income from continuing operations before income taxes was $929,687 against $457,113 a year ago. Net income from continuing operations was $896,222 or $0.11 per diluted share against $454,363 or $0.06 per diluted share a year ago. Net income was $901,197 or $0.11 per diluted share against $459,338 or $0.06 per diluted share a year ago. For the six months period, the company reported net sales of $10,140,345 against $7,197,643 a year ago. Loss from operations was $5,601,008 against $4,122,059 a year ago. Loss from operations was $860,149 against $2,139,773 a year ago. Income from continuing operations before income taxes was $1,322,261 against loss of $429,114 a year ago. Net income from continuing operations was $1,274,444 or $0.16 per diluted share against loss of $434,614 or $0.06 per diluted share a year ago. Net income was $1,284,394 or $0.16 per diluted share against $424,664 or $0.06 per diluted share a year ago.

Misonix, Inc. to Report Q2, 2015 Results on Feb 04, 2015

Misonix, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Feb 04, 2015

Misonix, Inc., Q2 2015 Earnings Call, Feb 04, 2015

Misonix, Inc., Q2 2015 Earnings Call, Feb 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $13.14 USD -0.04

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.31 USD -0.03
Globus Medical Inc $23.51 USD -0.35
NuVasive Inc $46.65 USD +0.99
Smith & Nephew PLC 1,111 GBp -3.00
Synergetics USA Inc $4.60 USD -0.19
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings 36.4x
Price/Sales 5.0x
Price/Book 5.5x
Price/Cash Flow 32.4x
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.